Fulcrum Therapeutics Shares Rise 26% on Sickle Cell Disease Market Opportunity

WSJSep 27 00:41

12 Health Care Stocks Moving In Thursday's Intraday Session

BenzingaSep 27 00:31

Fulcrum Therapeutics Potential Winner After Pfizer Pulls Oxbryta -- Market Talk

WSJSep 27 00:17

Express News | Fulcrum Therapeutics Shares up 31% After Rival Pfizer Withdraws Sickle Cell Disease Treatment

BreakingsSep 26 22:04

Fulcrum Therapeutics to Cut Jobs, Reprioritize R&D Activities

MT NewswiresSep 25 05:27

Fulcrum Reduces Its Workforce

Seeking AlphaSep 25 05:00